Recess raises $5 million in Series A funding led by Spring Mountain Capital and Data Point Capital.
Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, today announced the close of a $21.5 million Series B financing.
Keen Decision Systems (“Keen”) announced today that it has closed an $11 million Series B financing led by Ballast Point Ventures IV (“BPV”) to accelerate the industry’s first and only decision optimization engine rooted in predictive analytics
Thentia raises $10 million Series B1 Financing led by Spring Mountain Capital and BDC Capital
Genomenon raises $20 million Series B Financing led by Spring Mountain Capital and Beringea
Spring Mountain Capital completes successful sale of OpenSlate to DoubleVerify for $150 million
Thentia Cloud becomes state-supported software provider for occupational licensing in Oklahoma
RepairSmith raises $42 million in Series B funding led by Spring Mountain Capital, TI Capital, Mercedes-Benz, and Porsche Ventures
Maven raises $110 million in Series D funding co-led by Dragoneer and Lux Capital at a $1 billion valuation
Maven CEO Kate Ryder receives the Disruptive Founder of the Year award from Rock Health, Goldman Sachs, and Fenwick & West.
The Scientist names IsoPlexis single-cell intracellular proteome a Top 10 Innovation of 2020
Oncoceutics ONC201 featured in National Cancer Institute article "As Use of Genomic Data Expands in Cancer Care, Patients Share Their Stories"
180 Health Partners featured on NPR podcast "In The Fight For Money For The Opioid Crisis, Will The Youngest Victims Be Left Out?"
OpenSlate announces strategic investment by Nielsen to offer customers digital content-quality ratings
Kate Ryder appears on NBC Today show to discuss how Maven is working to close the gap in women's wellness
ReNetX Bio, Inc. announces U.S. FDA authorization to proceed for IND application to treat patients with Chronic Spinal Cord Injury
FDA grants fast track designation to ONC201 for the treatment of Adult Recurrent H3 K27M-mutant High-Grade Glioma
RiskSense raises $12 million in Series B funding round co-led by Spring Mountain Capital and NightDragon Security
Doctor.com recognized by Google as the only Google My Business (GMB) partner focused on healthcare
IsoPlexis collaborates with Kite Pharma to publish clinical data in Blood highlighting the potential to predict which cancer patients will respond to CAR-T cell therapy
Vergent Bioscience raises $8.7 million in Series A financing led by Spring Mountain Capital